{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:48:42Z","timestamp":1786373322723,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.2215\/cjn.02370314","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T00:10:49Z","timestamp":1413418249000},"page":"1903-1911","source":"Crossref","is-referenced-by-count":36,"title":["Relationship between Serum Soluble Urokinase Plasminogen Activator Receptor Level and Steroid Responsiveness in FSGS"],"prefix":"10.2215","volume":"9","author":[{"given":"Furong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minlin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20230601","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1056\/NEJMra1106556","article-title":"Focal segmental glomerulosclerosis.","volume":"365","author":"D\u2019Agati","year":"2011","journal-title":"N Engl J Med"},{"key":"R2-14-20230601","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000313947","article-title":"Immunopathogenesis of idiopathic nephrotic syndrome.","volume":"169","author":"Zhang","year":"2011","journal-title":"Contrib Nephrol"},{"key":"R3-14-20230601","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/153537020422900111","article-title":"The focal segmental glomerulosclerosis permeability factor: Biochemical characteristics and biological effects.","volume":"229","author":"Sharma","year":"2004","journal-title":"Exp Biol Med (Maywood"},{"key":"R4-14-20230601","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM199604043341402","article-title":"Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.","volume":"334","author":"Savin","year":"1996","journal-title":"N Engl J Med"},{"key":"R5-14-20230601","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00467-010-1692-x","article-title":"Pathogenesis and therapy of focal segmental glomerulosclerosis: An update.","volume":"26","author":"Gbadegesin","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"R6-14-20230601","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.2215\/CJN.03800609","article-title":"Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.","volume":"5","author":"McCarthy","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R7-14-20230601","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1681\/ASN.V103529","article-title":"Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: Evidence for increased IL-13 mRNA expression in relapse.","volume":"10","author":"Yap","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R8-14-20230601","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1043-4666(03)00017-6","article-title":"Implications of serum TNF-beta and IL-13 in the treatment response of childhood nephrotic syndrome.","volume":"21","author":"Tain","year":"2003","journal-title":"Cytokine"},{"key":"R9-14-20230601","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3476(79)80665-4","article-title":"Recurrence of steroid-responsive nephrotic syndrome after renal transplantation.","volume":"95","author":"Mauer","year":"1979","journal-title":"J Pediatr"},{"key":"R10-14-20230601","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/ndt\/16.2.416","article-title":"Successful transplant of a kidney with focal segmental glomerulosclerosis.","volume":"16","author":"Rea","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R11-14-20230601","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med"},{"key":"R12-14-20230601","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor.","volume":"14","author":"Wei","year":"2008","journal-title":"Nat Med"},{"key":"R13-14-20230601","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1681\/ASN.2012030302","article-title":"Circulating suPAR in two cohorts of primary FSGS.","volume":"23","author":"Wei","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R14-14-20230601","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ki.2013.55","article-title":"Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis.","volume":"84","author":"Huang","year":"2013","journal-title":"Kidney Int"},{"key":"R15-14-20230601","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ki.2013.505","article-title":"The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis.","volume":"85","author":"Meijers","year":"2014","journal-title":"Kidney Int"},{"key":"R16-14-20230601","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ki.2013.544","article-title":"A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease.","volume":"85","author":"Wada","year":"2014","journal-title":"Kidney Int"},{"key":"R17-14-20230601","first-page":"CD003233","article-title":"Immunosuppressive treatment for focal segmental glomerulosclerosis in adults.","volume":"16","author":"Braun","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"R18-14-20230601","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ki.2010.485","article-title":"Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life.","volume":"79","author":"Gipson","year":"2011","journal-title":"Kidney Int"},{"key":"R19-14-20230601","first-page":"53","article-title":"The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study.","volume":"36","author":"Banfi","year":"1991","journal-title":"Clin Nephrol"},{"key":"R20-14-20230601","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/qjmed\/hci072","article-title":"Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units.","volume":"98","author":"Stirling","year":"2005","journal-title":"QJM"},{"key":"R21-14-20230601","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1681\/ASN.2012040389","article-title":"Treatment of primary FSGS in adults.","volume":"23","author":"Korbet","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R22-14-20230601","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/ki.2012.280","article-title":"The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines\u2014application to the individual patient.","volume":"82","author":"Radhakrishnan","year":"2012","journal-title":"Kidney Int"},{"key":"R23-14-20230601","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1517\/13543781003765461","article-title":"The accumulated experience with the use of mycophenolate mofetil in primary glomerulonephritis.","volume":"19","author":"Koukoulaki","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"R24-14-20230601","doi-asserted-by":"crossref","first-page":"c189","DOI":"10.1159\/000199459","article-title":"Mycophenolate mofetil in high-risk patients with primary glomerulonephritis: results of a 1-year prospective study.","volume":"111","author":"Dimkovic","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"R25-14-20230601","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1681\/ASN.2004070593","article-title":"Focal and segmental glomerulosclerosis: Definition and relevance of a partial remission.","volume":"16","author":"Troyanov","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R26-14-20230601","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5414\/CN107607","article-title":"The clinical course and long-term outcome of primary focal segmental glomerulosclerosis in Chinese adults.","volume":"80","author":"Tang","year":"2013","journal-title":"Clin Nephrol"},{"key":"R27-14-20230601","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","article-title":"Pathologic classification of focal segmental glomerulosclerosis: A working proposal.","volume":"43","author":"D\u2019Agati","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R28-14-20230601","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.03531006","article-title":"Adult minimal-change disease: Clinical characteristics, treatment, and outcomes.","volume":"2","author":"Waldman","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R29-14-20230601","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","article-title":"A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.","volume":"58","author":"Schwartz","year":"1976","journal-title":"Pediatrics"},{"key":"R30-14-20230601","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R32-14-20230601","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2215\/CJN.07680712","article-title":"Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: A single-center report.","volume":"8","author":"Bock","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R33-14-20230601","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/TP.0b013e3182977ab1","article-title":"Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.","volume":"96","author":"Franco Palacios","year":"2013","journal-title":"Transplantation"},{"key":"R34-14-20230601","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/sj.ki.5000160","article-title":"Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants.","volume":"69","author":"Thomas","year":"2006","journal-title":"Kidney Int"},{"key":"R35-14-20230601","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4103\/0377-4929.64339","article-title":"Morphological features and prognostic significance of tip variant of focal segmental glomerulosclerosis: Study of an Indian cohort.","volume":"53","author":"Malhotra","year":"2010","journal-title":"Indian J Pathol Microbiol"},{"key":"R36-14-20230601","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: A disorder of T-cell function.","volume":"2","author":"Shalhoub","year":"1974","journal-title":"Lancet"},{"key":"R37-14-20230601","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ki.1991.232","article-title":"A glomerular permeability factor produced by human T cell hybridomas.","volume":"40","author":"Koyama","year":"1991","journal-title":"Kidney Int"},{"key":"R38-14-20230601","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1681\/ASN.2013080852","article-title":"Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence.","volume":"25","author":"Ding","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R39-14-20230601","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.semnephrol.2011.06.003","article-title":"Focal and segmental glomerulosclerosis: Multiple pathways are involved.","volume":"31","author":"Meyrier","year":"2011","journal-title":"Semin Nephrol"},{"key":"R40-14-20230601","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2215\/CJN.06170613","article-title":"Is there clinical value in measuring suPAR levels in FSGS?","volume":"8","author":"Sever","year":"2013","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201411000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:44:46Z","timestamp":1786369486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201411000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.02370314","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}